JENNIFER BURGESS: Open Payments
NPI 1194104240 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $129 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $224 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
| Corium, LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: CAPLYTA, Qelbree, INGREZZA, ARISTADA, VRAYLAR, Azstarys, Jornay PM.
Industry payments across AZ — which companies pay providers there.
